12 Nov 2015

Q3 15: slowly back to normality

STADA Arzneimittel AG (0OM4:LON) | 0 0 (-0.1%) | Mkt Cap: 5,400m

- Fabrice Farigoule
- 2 pages

Stada released 9m figures. They show revenues of €1,533.5m (+3%), EBITDA of €281.2m (-4%), and a net income of €89.9m (-9%). Free-cash flow amounted to €10.6m and net debt at the end of Q3 15 reached €1.3bn. The group confirmed its outlook for FY15 ("a substantial decrease in adjusted EBITDA and net income and a net debt/EBITDA ratio of c.3x excluding acquisitions").

Sign up to access

Get access to our full offering from over 30 providers

See all the research we have on this company.

Q3 15: slowly back to normality

STADA Arzneimittel AG (0OM4:LON) | 0 0 (-0.1%) | Mkt Cap: 5,400m

Published: 12 Nov 2015
Author: Fabrice Farigoule
Pages: 2

Stada released 9m figures. They show revenues of €1,533.5m (+3%), EBITDA of €281.2m (-4%), and a net income of €89.9m (-9%). Free-cash flow amounted to €10.6m and net debt at the end of Q3 15 reached €1.3bn. The group confirmed its outlook for FY15 ("a substantial decrease in adjusted EBITDA and net income and a net debt/EBITDA ratio of c.3x excluding acquisitions").